![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 282, Issue 1, 378-384, 1997
Department of Medicine, Division of Gastroenterology and Hepatology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania
 |
Abstract |
|---|
 Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
|
|---|
Studies were performed on the internal anal sphincter (IAS) smooth muscle strips obtained from opossums (Didelphis virginiana). Isometric tension and L-arginine levels of the tissues were measured under basal conditions, in the presence of electrical field stimulation (EFS) and after treatment with different concentrations of arginase. For the nonadrenergic noncholinergic nerve stimulation, short trains (4 sec) as well as continuous EFS were used. During continuous EFS, after the initial IAS relaxation, the response began to fade within several min to ~80% recovery of the basal tone. We also examined the influence of L-arginine and L-citrulline on these responses. For some studies, the tissues were pretreated with L-glutamine (an inhibitor of L-citrulline uptake), L-glutamate or NG-hydroxy-L-arginine (an inhibitor of arginase). Interestingly, the basal levels of L-arginine were found to be significantly higher in the IAS (tonic smooth muscle) than in the rectal (phasic smooth muscle) smooth muscle. Arginase caused a concentration-dependent attenuation of the IAS relaxation caused by EFS. L-Citrulline and L-arginine were equipotent in reversing the attenuation. Both arginase (60 min pretreatment) and continuous EFS (tissues collected at the time of maximal recovery of the basal IAS tone after the initial relaxation) caused significant decreases in L-arginine levels. The decreases in the levels of L-arginine were restored by the exogenous administration of either L-arginine or L-citrulline. The restoration of L-arginine levels by L-citrulline but not by L-arginine was selectively blocked by L-glutamine. Furthermore, the IAS relaxation, attenuated by arginase was unaffected by L-glutamine but was restored by NG-hydroxy-L-arginine pretreatment. The studies suggest that L-citrulline-L-arginine recycling may play a significant role in the maintenance of IAS relaxation in response to nonadrenergic noncholinergic nerve stimulation.
| |
Introduction |
|---|
|
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
|
|---|
The IAS relaxation in response to
NANC nerve stimulation with short train EFS can be maintained for
several hours without a significant fade. Furthermore, we have recently
reported that the IAS relaxation in response to continuous EFS can be
maintained for several min that is followed by a gradual recovery of
the basal tone toward the prestimulus level (Rattan et al.,
1996
). The exact mechanism responsible for the maintenance of the IAS relaxation and for the fade is not known.
Different laboratories have identified the role of multiple inhibitory
neurotransmitters such as vasoactive intestinal polypeptide (Biancani
et al., 1985; Nurko and Rattan, 1988), NO (Rattan and Chakder, 1992; Rattan et al., 1992; Tottrup et
al., 1992) and possibly heme oxygenase pathway (Rattan and
Chakder, 1993; Tottrup et al., 1995) in the relaxation of
IAS. The inhibitory substances appear to work either independently or
in concert with other inhibitory neurotransmitters. For example, a part
of the inhibitory action of vasoactive intestinal polypeptide in the
IAS is mediated via L-arginine-NO pathway (Rattan and
Chakder, 1992). The role of NO as an inhibitory neurotransmitter in the
opossum IAS is similar to that of humans (Burleigh, 1992; O'Kelly
et al., 1993). In addition, adenosine triphosphate has also
been suggested to play a role in the inhibitory neurotransmission in
the IAS of the rabbit (Tottrup et al., 1995; Knudsen
et al., 1995) and the guinea pig (Rae and Muir, 1996).
It is well known that in the central nervous system as well as in the
peripheral autonomic nervous system, NO and L-citrulline are produced stoichiometrically (1:1) from L-arginine by
NOS (Moncada et al., 1991; Goyal and Hirano, 1996; Makhlouf
and Grider, 1993; Moncada and Higgs, 1993; Bush et al.,
1992; Jaffrey and Snyder, 1995; Stark and Szurszewski, 1992; Sanders
and Ward, 1992). Although, the role of L-citrulline
recycling to L-arginine in a number of systems is well
known, its role in the gastrointestinal tract has only been recognized
recently (Shuttleworth et al., 1995; Rattan et
al., 1996). In the IAS and colon, the inhibition of NOS has been
shown to cause significant attenuation of the smooth muscle relaxation
that can be overcome enantiomer-specifically not only by
L-arginine but also by L-citrulline. The data
suggest the presence of enzymatic machinery responsible for the
recycling of L-citrulline into L-arginine
(Shuttleworth et al., 1995; Yu et al., 1995). The
studies showed that L-citrulline can substitute for
L-arginine to restore the inhibitory neurotransmission
inhibited by the NOS inhibitor. However, direct studies to demonstrate
changes in L-arginine levels to test the hypothesis have
not been performed.
The purpose of our investigation was to further examine the role of L-citrulline recycling in the IAS smooth muscle relaxation by the simultaneous determinations of tissue levels of L-arginine. Arginase pretreatment and continuous EFS were used to determine the influence of L-arginine deficiency on the IAS relaxation, and the role of L-citrulline-L-arginine recycling in the maintenance of IAS relaxation.
| |
Materials and Methods |
|---|
|
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
|
|---|
Preparation of smooth muscle strips.
Adult opossums
(Didelphis virginiana) of either sex weighing from 2.3 to
3.6 kg, were killed after a high dose of pentobarbital sodium (50 mg/kg; i.p.). The anal canal along with a section of the rectum was
removed and transferred to oxygenated Krebs physiological solution of
the following composition (in mM): NaCl, 118.07; KCl, 4.69;
CaCl2, 2.52; MgSO4, 1.16;
NaH2PO4, 1.01; NaHCO3, 25 and glucose, 11.10. The anal canal was freed of all extraneous tissues including the external anal sphincter by sharp dissection, opened and
pinned flat on a dissecting tray containing oxygenated Krebs solution.
The mucosal and submucosal layers were carefully removed using sharp
dissection and IAS circular smooth muscle strips (~1 × 10 mm)
were prepared as described previously (Moummi and Rattan, 1988).
Measurement of isometric tension.
The muscle strips were
secured at both ends with silk sutures and transferred to 2-ml muscle
baths containing oxygenated (95% oxygen plus 5% carbon-dioxide)
Krebs' solution (34°C). One end of the muscle strip was anchored at
the bottom of the muscle bath and the other end was attached to a force
transducer (model FTO3; Grass Instruments Co., Quincy, MA) for the
measurement of isometric tension on a Dynograph recorder (model R411;
Beckman Instruments, Schiller Park, IL). The muscle strips were
stretched initially at 1 g of tension and allowed to equilibrate
for at least 1 hr by replacement of bath solution with fresh oxygenated
Krebs solution at 20-min intervals. The IAS smooth muscle strips
developed spontaneous and steady tension during this equilibration
period. Only the strips that developed spontaneous tension and relaxed
in response to EFS were used for the study. The optimal length
(Lo)and the baseline of the smooth muscle strips were
determined as described previously (Moummi and Rattan, 1988).
NANC nerve stimulation with EFS. EFS was delivered from a Grass stimulator (model S88; Grass Instruments Co.) via platinum electrodes consisting of a pair of platinum wires fixed at both sides of the smooth muscle preparation. Neurally mediated relaxation of the IAS smooth muscle strips was measured in response to different frequencies (0.5-20 Hz) of EFS (20-30 V, 0.5-sec pulse duration for 4 sec). These parameters of EFS are known to cause IAS relaxation by selective activation of NANC myenteric neurons. Two EFS protocols were used for the study.
In the first protocol, the NANC nerves were stimulated with short train EFS (4-sec train; 0.5-msec pulse duration; 20-30 V) at varying frequencies (0.5-20 Hz) before and after treatment with different drugs. In these experiments, the smooth muscle strips showed transient relaxation. This protocol was used for the functional studies dealing with the influence of arginase treatment alone and arginase plus either L-arginine or L-citrulline on EFS-induced IAS relaxation. In the second protocol, long trains of EFS usually for 20 to 45 min (0.5-msec pulse duration; 20-30 V; 5, 10 or 20 Hz) were used. On application of continuous EFS, the smooth muscle strips responded with an immediate relaxation. The immediate and full relaxation in the presence of ongoing EFS was followed by a gradual recovery of the basal tone toward the prestimulus level. A recovery ranging from 80 to 100% was observed in 15 to 30 min. At this time, the basal IAS tension became stable and the smooth muscle strips were treated with different drugs. This type of protocol was used to determine the relationship between the reversal of the IAS relaxation during the EFS and L-arginine levels before and after different manipulations. Two types of protocols were used to produce arginine deficiency and determine its effect on the IAS relaxation. In the first protocol, arginase pretreatment was used at different concentrations (15, 30 or 60 U/ml in the muscle baths) for 60 min. The influence of arginase on the basal IAS tone, NANC nerve-mediated IAS relaxation and on the basal L-arginine levels were determined. In the second type, continuous EFS was used as explained above. To determine the effects of L-citrulline and L-arginine on the influence of L-arginine deficiency by arginase pretreatment or continuous EFS, the tissues were treated with L-arginine or L-citrulline for 30 min.L-Arginine determinations.
Depletion
of L-arginine in the IAS smooth muscle strips was attempted
either by arginase pretreatment (60 U/ml at 37°C for 60 min) or
continuous EFS (10 Hz) and the tissues were frozen quickly as described
previously (Rattan et al., 1991). To examine the effects of
L-arginine or L-citrulline, the tissues were
treated with these agents for another 30 min and the tissues quick
frozen at this time.
). Briefly, samples (3 ml) were taken into
different tubes on an ice bath and treated with 0.5 ml of alkaline 
naphthol-thymine mixture and mixed well. The samples were then treated
with 0.2 ml of 1% sodium hypochloride (NaOCl) solution and mixed
immediately. Exactly, 1 min later 0.2 ml of 2% sodium thiosulphate was
added and mixed well. The absorbance of the samples were measured at 515 nm using a spectrophotometer (model DU 64; Beckman Instruments Inc., Fullerton, CA). Recovery of L-arginine from the
tissues was determined by adding known amounts of
L-arginine to some smooth muscle strips and measurements of
arginine levels colorimetrically after the extraction process. The
recovery of added arginine through the extraction procedure was
84.3 ± 3.5%. No correction factor for the percentage of recovery
was applied for the calculation of tissue arginine levels. The protein
content of the tissues was determined by the method of Lowry et
al. (1951).
Drug Responses. Responses to different agents were examined using either single dose or cumulative concentration responses. Once the concentration-response curve to an agent was determined, the smooth muscle strips were washed for 45 min, and the basal tension was allowed to recover. The effects of agents on the NANC nerve-mediated IAS relaxation was determined using both short train and continuous EFS.
L-Arginine deficiency was monitored by the determination of L-arginine levels before and after arginase and at appropriate times of the continuous EFS as explained above. The influence of these maneuvers was further ascertained by the effect of L-arginine deficiency on EFS-induced IAS relaxation. Furthermore, the possible restoration of these parameters (L-arginine levels and NANC nerve-mediated IAS relaxation) was examined after the administration of L-arginine and L-citrulline. We also performed studies to examine the influence of L-glutamine (putative blocker of L-citrulline uptake) (Lee et al., 1996; Sessa et al., 1990) on
the L-arginine levels before and after L-arginine and L-citrulline in the presence of
continuous EFS. To determine the specificity of action of
L-glutamine, we examined the effects of
L-glutamate. The tissues were pretreated with
L-glutamine or L-glutamate for 30 min before
testing the effects of EFS and L-citrulline or
L-arginine. The effects of different concentrations of
L-citrulline or L-arginine on the basal tone,
NANC nerve-mediated IAS relaxation and recovered IAS tone in the
presence of ongoing EFS were also determined before and after
L-glutamine.
To determine the specificity of action of arginase, in a separate
series of experiments, we also examined the effects of
NG-hydroxy-L-arginine (HOArg) an inhibitor of
arginase (Hecker et al., 1995), on the effects of arginase
on L-arginine levels and IAS relaxation.
Drugs and chemicals. The following chemicals were used in the study: arginase, L-arginine hydrochloride, D-arginine, L-citrulline (L-2-amino-5-ureidovaleric acid), L-glutamine (L-2-aminoglutamic acid), L-glutamic acid monosodium salt (L-glutamate), NG-hydroxy-L-arginine (HOArg) (Sigma Chemical Co., St. Louis, MO); and ethylenediaminetetracetic acid tetrasodium salt (Fisher Scientific, Pittsburgh, PA). All chemicals were dissolved and diluted in Krebs solution and prepared fresh on the day of the experiment. The pH of the solutions was adjusted to 7.4. The vials and pipette tips were siliconized whereas the muscle baths were treated with 2.5% bovine serum albumin.
Data analysis. The results are expressed as means ± S.E. of different experiments. The fall in the basal IAS tension was expressed as percent of maximal fall (100%) of tension caused by 5 mM ethylenediaminetetracetic acid. Statistical significance between different groups were determined using t test (paired or unpaired) or analysis of varianace and p < .05 was considered statistically significant.
| |
Results |
|---|
|
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
|
|---|
Effect of different concentrations of arginase on IAS relaxation by
NANC nerve stimulation: influence of L-arginine
and L-citrulline.
Short train (4 sec) EFS
was used in these experiments before and after arginase pretreatment.
As shown in figure 1, in control experiments, EFS caused
a frequency-dependent fall in the basal tension of the IAS. Arginase
pretreatment caused attenuation in the IAS relaxation caused by
different frequencies of EFS (Fig. 1).
|
3 M caused a
complete reversal of the IAS relaxation. The reversal of the IAS
relaxation by L-arginine was stereoselective since D-arginine 1 × 103 M had no
effect on the attenuated IAS relaxation. Interestingly, L-citrulline had similar effects in reversing the
attenuation of IAS relaxation as L-arginine (fig.
3) in arginase-treated preparations. However, neither
L-arginine nor L-citrulline had any effect on the EFS-induced IAS relaxations in arginase untreated tissues (L-arginine sufficient). The data suggest that arginase was
selective in suppressing the IAS relaxation caused by EFS.
|
|
).
To substantiate that the attenuation of the IAS relaxation and
its reversal by L-arginine and L-citrulline are
directly associated with L-arginine depletion and
repletion, respectively, we performed L-arginine
determinations in the basal state, after arginase pretreatment and
arginase plus L-arginine or L-citrulline.
Arginase pretreatment was found to cause no significant effect on the
basal tone of the IAS. The basal IAS tone before and after arginase
pretreatment (60 U/ml) were 2.12 ± 0.18 and 2.19 ± 0.19 g, respectively (P > .05; n = 5).
Interestingly, the basal levels of L-arginine were found to
be significantly higher in the IAS (6.15 ± 0.57 pmol/µg
protein) than in the rectum (3.91 ± 0.52 pmol/µg protein)
(P < .05; n = 4). In three of the four animals
investigated, the basal levels of L-arginine were
distinctly lower in the rectum.
Effect of arginase treatment on L-arginine
levels: influence of L-citrulline and
L-arginine.
In these tissues used for the
isometric tension studies, the basal level of L-arginine in
the IAS was found to be 6.2 ± 0.7 pmol/µg protein. After the
treatment with arginase, L-arginine levels were 4.3 ± 0.9 pmoles/µg protein (P < .05; n = 4; fig. 4).
L-Arginine and L-citrulline after arginase
pretreatment in these tissues caused a significant reversal of the
decrease in L-arginine levels to 8.1 ± 1.2 and
6.1 ± 0.3 pmol/µg protein respectively (P < .05;
n = 4; fig. 4).
|
Effect of continuous EFS on the IAS relaxation and
L-arginine levels: influence of
L-citrulline and
L-arginine.
In these series of
experiments, continuous EFS caused a significant fall in the basal
levels of L-arginine from 8.2 ± 0.7 to 6.5 ± 0.7 pmol/µg protein (P < .05; n = 7; fig.
5). The treatment of the tissues with
L-arginine or L-citrulline in the presence of
continuous EFS caused a restoration of the L-arginine
levels. The concentrations of L-arginine and
L-citrulline were selected for these experiments because
they caused maximal reversal of the IAS relaxations.
|
Influence of L-glutamine on the restoration of L-arginine levels by L-citrulline. To determine the role of L-citrulline recycling into L-arginine, we examined the effect of L-glutamine on L-arginine levels of the IAS tissues during continuous EFS before and after L-arginine or L-citrulline. L-Glutamine blocked the reversal of the EFS-induced decrease in the L-arginine levels by L-citrulline (fig. 5). L-Arginine levels in these experiments during continuous EFS after L-citrulline were 7.8 ± 0.5 pmol/µg protein and after L-citrulline plus L-glutamine the levels were 6.7 ± 0.5 pmol/µg protein (P < .05; n = 5; Fig. 5). However, the reversal of the decrease in L-arginine levels by L-arginine were not significantly affected by L-glutamine (10.8 ± 1.5 pmol/µg protein after L-arginine alone vs. 10.2 ± 0.7 pmol/µg protein after L-arginine plus L-glutamine) (P > .05; n = 5). Furthermore, our preliminary studies showed that L-glutamate had no effect on the restoration of L-arginine levels by either L-arginine or L-citrulline.
Influence of L-glutamine and
NG-hydroxy-L-arginine
(HOArg) on the fall in IAS tension by NANC nerve stimulation.
The
effects of L-glutamine and HOArg on the attenuation of
EFS-induced IAS relaxation by arginase are shown in figure
6, A and B. The data show that the attenuation of
EFS-induced IAS relaxation by arginase (30 U/ml) (fig. 6A) was not
affected by L-glutamine (1 × 103 M) but the attenuation was reversed by
pretreatment of the tissues with HOArg (1 × 104 M) (fig. 6B). The data suggest the
specificity of action of arginase and L-glutamine. Effects
of the NO-donor SNP on the basal tension of the IAS before and after
continuous EFS and arginase treatment
|
|
| |
Discussion |
|---|
|
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
|
|---|
The studies suggest that the critical levels of L-arginine and recycling of L-citrulline to L-arginine are important in the maintenance of IAS relaxation by NANC nerve stimulation.
In our study, two types of experimental protocols were used to
investigate the role of L-arginine deficiency: continuous
EFS and arginase treatment. Continuous EFS causes an immediate fall in
the IAS tension followed by a gradual recovery of the tone to ~80%
of the original tone. The recovery of the tone in the presence of
continuous EFS was speculated to be due to the depletion of
L-arginine (Rattan et al., 1996). Our studies
with the measurement of L-arginine levels provide direct
evidence in that regard. There was a significant decrease in the levels
of L-arginine from the basal state to the time when the IAS
relaxation had recovered. Furthermore, at this time, the administration
of L-citrulline leads to the restoration of
L-arginine levels. The restoration of
L-arginine levels by L-citrulline was similar
to that by L-arginine. Furthermore, our previous studies
have shown that L-citrulline as well as
L-arginine cause concentration-dependent fall in the recovered basal tone of the IAS in the L-arginine
deficiency state caused by the continuous EFS.
Arginase pretreatment causes a state similar to that of continuous EFS
because it causes an attenuation of neurally mediated IAS relaxation
and decrease in the tissue levels of L-arginine. The
decrease in the levels of L-arginine and the IAS relaxation can be resorted by the exogenous administration of
L-arginine or L-citrulline. The data provide
further evidence in support of the role of L-arginine-NO
pathway and L-citrulline-L-arginine recycling
in the IAS relaxation by NANC nerve stimulation (Rattan and Chakder,
1992; Rattan et al., 1992).
It is interesting that complete depletion of L-arginine levels is not a requirement for the failure or significant suppression of the IAS relaxation by NANC nerve stimulation. The data suggest that there is a critical level of L-arginine that must be maintained for the normal relaxation during the NANC nerve stimulation. As a matter of fact, the studies clearly show that only a small decrease in the L-arginine levels in the tissues is all that is required to cause a dramatic impairment of the NANC nerve-mediated relaxation of the IAS. This is supported by an immediate and complete reversal of the IAS relaxation as well as the tissue levels of L-arginine by small concentrations of exogenous L-arginine. The concept of critical levels of basal L-arginine being responsible for the IAS relaxation is supported by the findings that exogenous L-arginine in the normal tissues (L-arginine adequate or sufficient tissues) usually causes no increase in the tissue levels of L-arginine. Furthermore, exogenous L-arginine in the L-arginine sufficient tissues causes neither a significant fall in the basal IAS tone nor a significant increase in the NANC nerve-mediated IAS relaxation. It is only in the L-arginine deficient preparation (either caused by continuous EFS or by arginase pretreatment) that a fall in the basal tone of the IAS and restoration of the attenuated IAS relaxation was observed.
The studies suggest that L-citrulline recycling may be
partly responsible for the maintenance of IAS relaxation. In the
earlier studies (Rattan et al., 1996), we showed that in the
normal (L-arginine sufficient tissues) tissues, neither
L-arginine nor L-citrulline had any significant
effect on the basal tone. However, in the L-arginine-deficient tissues (caused by the continuous
EFS), L-citrulline as well as L-arginine caused
concentration-dependent fall in the basal tone of the IAS. The concept
is similar to that proposed by Shuttleworth et al. (1995) in
the canine colon. The authors showed that the inhibitory
neurotransmission suppressed by the NOS inhibitor was restored by
L-citrulline as well as by L-arginine. Furthermore, the investigators showed the presence of enzymatic machinery (argininosuccinate synthetase and argininosuccinate lyase)
responsible of the synthesis of L-arginine. In our study we
show the restoration of the IAS relaxation as well as the
L-arginine levels by both exogenous L-arginine
and L-citrulline during prolonged EFS. The specificity of
the action of L-citrulline was further examined by the
pretreatment of tissues with L-glutamine, a putative inhibitor of L-citrulline uptake (Sessa et al.,
1990; Lee et al., 1996). Interestingly, although
L-glutamine blocked the recovery of L-arginine
levels as well as the IAS relaxation by L-citrulline in the
L-arginine-deficient preparations, it had no effect on the
recovery by L-arginine. The data provide further evidence in favor of the proposed mechanism of action of
L-glutamine. This further suggests the role of recycling of
L-citrulline into L-arginine being responsible
for the restoration of the IAS relaxation during continuous EFS.
Furthermore, L-glutamate an amino acid that otherwise resembles L-glutamine had no significant effect on the
restoration of L-arginine levels and the suppressed IAS
relaxation.
The data also suggest the presence of transport systems for extracellular L-arginine and L-citrulline in the myenteric neurons of the IAS. The exact nature of affinity carriers responsible for the transcellular transport of two amino acids in the myenteric neurons has not been characterized. Furthermore, the relative contribution of extracellular vs. intracellular sites of action of exogenous arginase in causing the suppression of IAS relaxation and decrease in L-arginine levels in the IAS also remains to be determined.
The suppression of the NANC nerve-mediated IAS relaxation by L-arginine deficiency was found to be specific since the IAS relaxation by the direct acting agent sodium nitroprusside was not affected by the maneuvers causing L-arginine deficiency. Furthermore, the arginase-induced attenuation of the IAS relaxation was specifically blocked by NG-hydroxy-L-arginine (arginase inhibitor) but not by L-glutamine.
Another interesting outcome of the studies was that in the basal state, significantly higher levels of L-arginine were found in the smooth muscle of internal anal sphincter than in the rectum. The observations suggest an active uptake and efficient handling of L-arginine in the IAS tissues. The significance of these observations and the cellular site(s) responsible for the contribution to the differences remains to be determined. It is possible that differences in the uptake of L-arginine, presence of membrane transporter, intracellular production of L-arginine by protein degradation and the L-citrulline-L-arginine recycling may be partly responsible for the efficient inhibitory neurotransmission and the difficulty in causing a complete depletion of L-arginine levels in the IAS tissues by any of the approaches used.
L-Arginine-NO pathway has been shown to play a significant
role in the appropriate peristalsis in the esophagus (Yamato et al., 1992; Murray et al., 1991; Anand and Paterson,
1994). Furthermore, it has been shown that the exogenous administration
of NO donor, glyceryl trinitrate but not L-arginine (NO
precursor) produces beneficial effect in such patients (Konturek
et al., 1995). The improvement in the esophageal motility
picture in these patients with the NO donor and the failure with
L-arginine suggest that the underlying etiology of diffuse
esophageal spasm may not be L-arginine deficiency, but it
may be related either to the loss of or damage to the myenteric
nitrergic neurons. Under these circumstances, the tissues may not be
expected to utilize the available or exogenously administered
L-arginine for the synthesis of NO.
In summary, the data show the importance of L-arginine-NOS pathway and a role of L-citrulline-L-arginine recycling in the maintenance of the gastrointestinal smooth muscle relaxation in response to NANC nerve stimulation.
| |
Footnotes |
|---|
Accepted for publication March 10, 1997.
Received for publication October 16, 1996.
1 The work was supported by United States Public Health Service Grant DK-35385 from the National Institutes of Health and an institutional grant from Thomas Jefferson University.
Send reprint requests to: Dr. Satish Rattan, Professor of Medicine and Physiology, 901 College, Department of Medicine, Division of Gastroenterology & Hepatology, 1025 Walnut Street, Philadelphia, PA 19107.
| |
Abbreviations |
|---|
IAS, internal anal sphincter; EFS, electrical field stimulation; NANC, nonadrenergic noncholinergic; NO, nitric oxide; NOS, nitric oxide synthase; HOArg, NG-hydroxy-L-arginine.
| |
References |
|---|
|
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
|
|---|
This article has been cited by other articles:
|
|
 |
|
  H W F M de Gouw, M B Verbruggen, I M Twiss, and P J Sterk Effect of oral L-arginine on airway hyperresponsiveness to histamine in asthma Thorax, November 1, 1999; 54(11): 1033 - 1035. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Baggio, F. A. Emig, D. W. Christianson, D. E. Ash, S. Chakder, and S. Rattan Biochemical and Functional Profile of a Newly Developed Potent and Isozyme-Selective Arginase Inhibitor J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1409 - 1416. [Abstract] [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|
 |
 |
 |
